HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Exempts Supplements From Redundant Regs, Suppliers Left Hanging

This article was originally published in The Tan Sheet

Executive Summary

The Senate's food safety reform bill relieves the dietary supplement industry's biggest concern about the legislation by excluding supplement firms from duplicative manufacturing regulations

You may also be interested in...



Safe Cosmetics Act Lays Groundwork For Future Action

The Safe Cosmetics Act of 2010, while a long shot for passage this year, likely will serve as a jumping-off point for future discussion, says food and drug attorney Mark Mansour

IoM report reminds Congress of food safety

Capital Hill proponents of food safety reform say an Institute of Medicine report recommending FDA use a more risk-based approach supports the need for legislation. Sen. Tom Harkin, D-Iowa, says IoM's June 8 1report shows "gaps still exist in our nation's food safety system." While the House has passed its bill - H.R. 2749 - Rep. John Dingell points out the Senate has yet to act on S. 510. "I don't know how many more reports need to be written ... before the Senate wakes up and realizes we have a real public health problem on our hands," the Michigan Democrat says. H.R. 2749 imposes general and targeted user fees and makes supplement firms subject to hazard analysis and critical control point-like provisions required across food products, but S. 510 proposes only targeted fees and excludes supplement manufacturers from HACCP provisions (2"The Tan Sheet" Nov. 23, 2009). In the report, IoM said FDA should focus data and expertise at points in the food production, distribution and handling chains with the greatest risk. While FDA is implementing risk-based strategies for enforcing safety in the production and handling of food products, the report said the agency often is reactive and is not focused on prevention

FDA Will Seek More Authority Over Manufacturing In Wake Of J&J Recalls

FDA will monitor more closely manufacturing operations and require comprehensive changes at firms with systemic quality deficiencies as a result of its investigation of Johnson & Johnson's McNeil Consumer Healthcare

Related Content

Topics

UsernamePublicRestriction

Register

OM013133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel